Earnings Volatility Drives These Stocks in a New Direction

  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased 5.97% to $0.63 in the quarter versus EPS of $0.67 in the year-earlier quarter. Revenue Rose 18.39% to $202.6 million from the year-earlier quarter.

Salix Pharmaceuticals Ltd. reported adjusted EPS income of $0.63 per share. By that measure, the company missed the mean analyst estimate of $0.68. It missed the average revenue estimate of $205.94 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

SLXP

CareFusion Corporation (NYSE:CFN) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share increased 20.41% to $0.59 in the quarter versus EPS of $0.49 in the year-earlier quarter. Revenue Decreased 1.96% to $901 million from the year-earlier quarter.

CareFusion Corporation reported adjusted EPS income of $0.59 per share. By that measure, the company beat the mean analyst estimate of $0.53. It missed the average revenue estimate of $909.16 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

CFN

Air Methods Corp. (NASDAQ:AIRM) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased to $-0.15 in the quarter versus EPS of $0.32 in the year-earlier quarter. Revenue Decreased 6.07% to $179.22 million from the year-earlier quarter.

Air Methods Corp. reported adjusted EPS loss of $0.15 per share. By that measure, the company missed the mean analyst estimate of $-0.07. It missed the average revenue estimate of $187.53 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

AIRM

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased 25% to $0.09 in the quarter versus EPS of $0.12 in the year-earlier quarter. Revenue Decreased 4.83% to $347.1 million from the year-earlier quarter.

Allscripts Healthcare Solutions, Inc. reported adjusted EPS income of $0.09 per share. By that measure, the company missed the mean analyst estimate of $0.14. It missed the average revenue estimate of $367.76 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

MDRX

Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share increased to $-0.42 in the quarter versus EPS of $-0.48 in the year-earlier quarter. Revenue Decreased 29.75% to $1.7 million from the year-earlier quarter.

Anacor Pharmaceuticals, Inc. reported adjusted EPS loss of $0.42 per share. By that measure, the company missed the mean analyst estimate of $-0.39. It missed the average revenue estimate of $2.57 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

ANAC

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business